[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.169.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1989

Hyperproliferation of Conjunctival Fibroblasts From Patients With Cicatricial Pemphigoid

Author Affiliations

From The Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh.

Arch Ophthalmol. 1989;107(7):1064-1067. doi:10.1001/archopht.1989.01070020126045
Abstract

• The characteristic conjunctival scarring in cicatricial pemphigoid is a consequence of subepithelial fibrosis. The fibroblast is the cellular element responsible for fibrosis. To increase the understanding of the pathogenesis of abnormal fibrosis in cicatricial pemphigoid, the growth characteristics of conjunctival fibroblasts, from untreated patients with cicatricial pemphigoid (n = 9) and normal controls (n = 6), were studied in tissue culture. The latent period until fibroblast outgrowth began from the conjunctival explant was determined, as were the plating efficiency and doubling time of cells from first-passage cultures. Outgrowths of fibroblasts from patients with cicatricial pemphigoid appeared significantly sooner than from controls, 8.1 3.8 vs 19.3 ± 6.4 (mean ± SD) days. While there was no significant difference in the plating efficiency between fibroblasts from cicatricial pemphigoid (mean ± SD, 116.4% ± 44.6%) and those from controls (71.0% ± 39.4%), the doubling time was significantly faster for cicatricial pemphigoid than for controls, 26.5 ± 8.5 vs 50.7 ± 7.8 hours. Thus, conjunctival fibroblasts from patients with cicatricial pemphigoid are hyperproliferative in tissue culture when compared with normal controls. Therefore, scarring, which characterizes cicatricial pemphigoid, may be due, in part, to excessive fibroblast proliferation.

References
1.
Foster CS, Wilson LA, Ekins MB:  Immunosuppressive therapy for progressive ocular cicatricial pemphigoid . Ophthalmology 1982;89:340-353.Article
2.
Roat MI, Thoft RA: Cicatricial pemphigoid, in Gold DH, Weingeist TA (eds): The Eye in Systemic Disease. Philadelphia, JB Lippincott, in press.
3.
Foster CS:  Cicatricial pemphigoid . Trans Am Ophthalmol Soc 1986;84;527-663.
4.
Mondino BJ, Brown SI:  Ocular cicatricial pemphigoid . Ophthalmology 1981;88:95-100.Article
5.
Harwick J, Roat MI, Capone A Jr, et al:  Topical 5-fluorouracil for the treatment of ocular cicatricial pemphigoid: Toxicity without therapeutic effect . Ophthalmology 1988;95( (suppl) ):162.Article
6.
Thoft RA, Friend J, Kinoshita S, et al:  Ocular cicatricial pemphigoid associated with hyperproliferation of the conjunctival epithelium . Am J Ophthalmol 1984;98:37-42.Article
7.
Andersen SR, Jensen OA, Kristensen EB, et al:  Benign mucous membrane pemphigoid: III. Biopsy . Acta Ophthalmol 1974;52:455-463.Article
8.
Galbavy EJ, Foster CS:  Ultrastructural characteristics of conjunctiva in cicatricial pemphigoid . Cornea 1985/1986;4:127-136.Article
9.
Botstein GR, Sherer GK, LeRoy EC:  Fibroblast selection in scleroderma, an alternative model of fibrosis . Arthritis Rheum 1982;25:189-195.Article
10.
Ristow HJ, Holley RW, Messmer TO:  Regulation of growth of fibroblasts . J Invest Dermatol 1978;71:18-23.Article
11.
Jumblatt M, Neufeld AH:  β-Adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture . Invest Ophthalmol Vis Sci 1983;24:1139.
12.
Ebato B, Friend J, Thoft RA:  Comparison of central and peripheral human corneal epithelium in tissue culture . Invest Ophthalmol Vis Sci 1987;28:1450-1456.
13.
Waters H, Walford RL:  Latent period for outgrowth of human skin explants as a function of age . J Gerontol 1964;25:381-383.Article
14.
Anastassiades TP, Ley J, Wood A, et al:  The growth kinetics of synovial fibroblastic cells from inflammatory and non-inflammatory arthropathies . Arthritis Rheum 1978;21:461-466.Article
15.
Martin GM, Sprague CA, Norwood H, et al:  Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia . Am J Pathol 1974;74:137-154.
16.
Yue BYJT, Duvall J, Goldberg MF, et al:  Nanophthalmic sclera: Morphological and tissue culture studies . Ophthalmology 1986;93:534-541.Article
17.
Priestley GC, Adams LW:  Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal . Br J Dermatol 1983;109:149-156.Article
18.
LeRoy EC:  Increased collagen synthesis by scleroderma skin fibroblasts in vitro . J Clin Invest 1974;54:880-889.Article
19.
Buckingham RB, Prince RK, Rodnan GP:  Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan . J Lab Clin Med 1983;101:659-669.
20.
McGuigan LJ, Quigley HA, Lutty G, et al:  The effects of D-penicillamine and daunorubicin on conjunctival fibroblast proliferation and collagen synthesis . Invest Ophthalmol Vis Sci 1988;29:112-118.
21.
Jimenez SA, Feldman G, Bashey RI, et al:  Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts . Biochem J 1986;237:837-843.
22.
Neilson EG, Jimenez SA, Phillips M:  Cell-mediated immunity in interstitial nephritis: III. T-Lymphocyte-mediated fibroblast proliferation and collagen synthesis: An immune mechanism for renal fibrogenesis . J Immunol 1980;125:1708-1714.
23.
Wahl SM, Wahl LM, McCarthy JB:  Lymphocyte-mediated activation of fibroblast proliferation and collagen production . J Immunol 1978;121:942-946.
24.
DeLustro F, Sherer GK, LeRoy EC:  Human monocyte stimulation of fibroblast growth by a soluble mediator(s) . J Reticuloendothel Soc 1980;28:519-532.
25.
Leibovich SJ, Ross R:  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro . Am J Pathol 1976;84:501-514.
26.
Savage K, Siebert E, Swann D:  The effect of platelet-derived growth factor on cell division and glycosaminoglycan synthesis by human skin and scar fibroblasts . J Invest Dermatol 1987;89:93-99.Article
27.
Postlethwaite AE, Lachman LB, Kang AH:  Stimulation of fibroblast proliferation by human interleukin 1 . Arthritis Rheum 1982;25( (suppl) ):27.
28.
Burke J, Foster S, Herschler J:  Aqueous humor as a modulator of growth in fibroblast cultures . Curr Eye Res 1982/1983;2:835-841.Article
29.
Fulcher S, Lui G, Houston LL, et al:  Use of immunotoxin to inhibit proliferating human corneal endothelium . Invest Ophthalmol Vis Sci 1988;29:755-759.
×